Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-01 @ 4:13 PM
Study NCT ID:
NCT05281068
Status:
UNKNOWN
Last Update Posted:
2022-05-02
First Post:
2022-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-06
First Submit QC Date:
None
Study First Post Date:
2022-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-29
Last Update Post Date:
2022-05-02
Last Update Post Date Type:
ACTUAL